|
|
©2004-2008, Quantum Laboratories,
Inc.. All rights reserved.
|
|
|
|
|
|
|
|
|
Bipolar
Disorders
•
Protocol CN138013-016: A Randomized, Double Blind Comparison
of the efficacy and Safety of Aripiprazole Intramuscular
formula, Lorazepam, or Placebo in the treatment of Acutely
Agitated Patients Diagnosed with Bipolar I Disorder, Manic
or Mixed.
For
more information please call (561) 687-2111
|
|
|
|
|
|
|
Our facility identifies and recruits appropriate patients and
monitors them during the study. If you qualify and consent to
participate, there will be no charge for your study medication
and office visits. Additionally, you are responsible for attendence
to regular scheduled appointments.
|
|
|
|
|
Fact:
During any one-year period, up to 50 million Americans suffer
from clearly diagnosable mental disorder involving a degree
of incapacity that interferes with employment, attendence at
school or daily life.
|
|
|
|